These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25257311)

  • 21. Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation.
    Li YW; Guo J; Shen H; Li J; Yang N; Frangou C; Wilson KE; Zhang Y; Mussell AL; Sudol M; Farooq A; Qu J; Zhang J
    Cell Cycle; 2016 Sep; 15(18):2497-505. PubMed ID: 27428284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mdm2 associates with Ras effector NORE1 to induce the degradation of oncoprotein HIPK1.
    Lee D; Park SJ; Sung KS; Park J; Lee SB; Park SY; Lee HJ; Ahn JW; Choi SJ; Lee SG; Kim SH; Kim DH; Kim J; Kim Y; Choi CY
    EMBO Rep; 2012 Feb; 13(2):163-9. PubMed ID: 22173032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properly dividing with YAP.
    Pfeifer GP
    Sci Signal; 2016 Mar; 9(417):fs3. PubMed ID: 26933061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Energy stress tames the Hippo pathway.
    Hariharan IK
    Nat Cell Biol; 2015 Apr; 17(4):362-3. PubMed ID: 25812520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells.
    Pons B; Armengol G; Livingstone M; López L; Coch L; Sonenberg N; Ramón y Cajal S
    Oncol Rep; 2012 Jan; 27(1):225-31. PubMed ID: 21922152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2.
    Yamasaki S; Nishida K; Yoshida Y; Itoh M; Hibi M; Hirano T
    Oncogene; 2003 Mar; 22(10):1546-56. PubMed ID: 12629518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.
    Alzahrani F; Clattenburg L; Muruganandan S; Bullock M; MacIsaac K; Wigerius M; Williams BA; Graham ME; Rigby MH; Trites JR; Taylor SM; Sinal CJ; Fawcett JP; Hart RD
    J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):15. PubMed ID: 28222762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.
    Verma S; Yeddula N; Soda Y; Zhu Q; Pao G; Moresco J; Diedrich JK; Hong A; Plouffe S; Moroishi T; Guan KL; Verma IM
    Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7363-7370. PubMed ID: 30918126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cell polarity protein Scrib functions as a tumor suppressor in liver cancer.
    Kapil S; Sharma BK; Patil M; Elattar S; Yuan J; Hou SX; Kolhe R; Satyanarayana A
    Oncotarget; 2017 Apr; 8(16):26515-26531. PubMed ID: 28460446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
    Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
    Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
    Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer.
    Lim B; Park JL; Kim HJ; Park YK; Kim JH; Sohn HA; Noh SM; Song KS; Kim WH; Kim YS; Kim SY
    Carcinogenesis; 2014 May; 35(5):1020-7. PubMed ID: 24325916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.
    Zhou D; Conrad C; Xia F; Park JS; Payer B; Yin Y; Lauwers GY; Thasler W; Lee JT; Avruch J; Bardeesy N
    Cancer Cell; 2009 Nov; 16(5):425-38. PubMed ID: 19878874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.
    Lu T; Li Z; Yang Y; Ji W; Yu Y; Niu X; Zeng Q; Xia W; Lu S
    Cancer Lett; 2018 Jun; 423():36-46. PubMed ID: 29452146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.
    Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell signaling: life or death decisions of ras proteins.
    Feig LA; Buchsbaum RJ
    Curr Biol; 2002 Apr; 12(7):R259-61. PubMed ID: 11937045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hippo/YAP, β-catenin, and the cancer cell: a "ménage à trois" in hepatoblastoma.
    Sylvester KG; Colnot S
    Gastroenterology; 2014 Sep; 147(3):562-5. PubMed ID: 25072176
    [No Abstract]   [Full Text] [Related]  

  • 38. NDR functions as a physiological YAP1 kinase in the intestinal epithelium.
    Zhang L; Tang F; Terracciano L; Hynx D; Kohler R; Bichet S; Hess D; Cron P; Hemmings BA; Hergovich A; Schmitz-Rohmer D
    Curr Biol; 2015 Feb; 25(3):296-305. PubMed ID: 25601544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
    Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
    Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.